Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: Eastern cooperative oncology group protocol E4402

Brad S. Kahl, Fangxin Hong, Michael E. Williams, Randy D. Gascoyne, Lynne I. Wagner, John C. Krauss, Thomas M. Habermann, Lode J. Swinnen, Stephen J. Schuster, Christopher G. Peterson, Mark D. Sborov, S. Eric Martin, Matthias Weiss, W. Christopher Ehmann, Sandra J. Horning

Research output: Contribution to journalArticlepeer-review

126 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: Eastern cooperative oncology group protocol E4402'. Together they form a unique fingerprint.

Medicine & Life Sciences